Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B supplementation and neuronal injury markers in HIV infection
2015-004311-20Phase 2Active
- Sponsor
- University of Gothenburg
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Triobe in human immunodeficiency virus infection (HIV) (2 arms), sponsored by University of Gothenburg. Primary endpoint: Change in plasma neurofilament light chain (NFL). Started Jan 2016; status: active.
02
Drugs
Triobe
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2015-004311-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004311-20.